Show simple item record

dc.contributor.authorArunga, Simon
dc.contributor.authorWiafe, Geoffrey
dc.contributor.authorHabtamu, Esmael
dc.contributor.authorOnyango, John
dc.contributor.authorGichuhi, Stephen
dc.contributor.authorLeck, Astrid
dc.contributor.authorMacleod, David
dc.contributor.authorHu, Victor
dc.contributor.authorBurton, Matthew
dc.date.accessioned2022-01-28T07:32:55Z
dc.date.available2022-01-28T07:32:55Z
dc.date.issued2019-12-23
dc.identifier.citationArunga, S., Wiafe, G., Habtamu, E., Onyango, J., Gichuhi, S., Leck, A., ... & Burton, M. (2019). The impact of microbial keratitis on quality of life in Uganda. BMJ open ophthalmology, 4(1), e000351.en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/1289
dc.description.abstractBackground: Microbial keratitis (MK) is a frequent cause of sight loss in sub-Saharan Africa. However, no studies have formally measured its impact on quality of life (QoL) in this context. Methods: As part of a nested case–control design for risk factors of MK, we recruited patients presenting with MK at two eye units in Southern Uganda between December 2016 and March 2018 and unaffected individuals, individually matched for sex, age and location. QoL was measured using WHO Health-Related and Vision-Related QoL tools (at presentation and 3 months after start of treatment in cases). Mean QoL scores for both groups were compared. Factors associated with QoL among the cases were analysed in a linear regression model. Results: 215 case-controlpairs were enrolled. The presentation QoL scores for the cases ranged from 20 to 65 20.7 (95% CI 18.8 to 22.7) and the highest was psychosocial domain; mean 65.6 (95% CI 62.5 to 68.8). At 3 months, QoL scores for the patients ranged from 80 to 90 points while scores for the controls ranged from 90 to 100. The mean QoL scores of the cases were lower than controls across all domains. Determinants of QoL among the cases at 3 months included visual acuity at 3 months and history of eye loss. Conclusion: MK severely reduces QoL in the acute phase. With treatment and healing, QoL subsequently improves. Despite this improvement, QoL of someone affected by MK (even with normal vision) remains lower than unaffected controls.en_US
dc.language.isoen_USen_US
dc.publisherBMJ Open Ophthalmologyen_US
dc.subjectMicrobial keratitisen_US
dc.subjectQuality of lifeen_US
dc.subjectSight lossen_US
dc.subjectUgandaen_US
dc.titleThe impact of microbial keratitis on quality of life in Ugandaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record